Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma
Thomas Jefferson University
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
AIDS Malignancy Consortium
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University
Northwestern University
Hoag Memorial Hospital Presbyterian
Fred Hutchinson Cancer Center